Skip to main content
. 2023 Feb 27;12(2):651–668. doi: 10.1007/s40120-023-00453-0

Fig. 2.

Fig. 2

Patient (left) and physician (right) dispositionaRespondent reported < 4 migraine headache days per month on average for the last 3 monthsbRespondent did not have chronic migraine (CM) or episodic migraine (EM), based on number of headache days; patients with ≥ 4 and < 15 headache days per month for > 3 months were considered to have episodic migraine and those with ≥ 15 headache days per month for > 3 months were considered to have chronic migrainecRespondent did not have headache of at least moderate severity, as evaluated by the Migraine Symptom Severity ScoredPreventive treatments for migraine that are available in Japan (e.g., valproate, topiramate, atenolol, nortriptyline)eDid not report ≥ 3 years of practice in one of the following medical specialties: neurology, neurosurgery, internal medicine